In the progress of hepatic fibrosis, HSCs are proliferated and activated by the stimulation of pro-fibrogenic cytokines including transforming growth factor-β (TGF-β), platelet derived growth factor-β (PDGF-β), or connective tissue growth factor (CTGF)3. The gene discussed is CCN2; the disease is Hepatic fibrosis.